A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world. A trial led by the Institute for Global Health revealed that most patients- 70 percent – reached blood pressure targets with the ‘Triple Pill’, compared to just over half receiving normal care. With high blood pressure the leading cause of disease burdens worldwide, it’s expected the findings published in JAMA will change guidelines globally.
Doctor in Institute for Global Health said this was a major advance by showing that the triple pill was not only more effective than standard care, it was also safe. “It's estimated more than a billion people globally suffer from high blood pressure with the vast majority having poorly controlled blood pressure. Our results could help millions of people globally reduce their blood pressure and reduce their risk of heart…
